Want to see JP:3645 full AI Analyst Report?
Top Page
Medical Net,Inc.
(3645)
Select Model
Select Model
Rating:62Neutral
Price Target:
¥269.00
▼(-9.73% Downside)
Action:Reiterated
Date:07/17/26
The score is primarily held back by inconsistent profitability and cash flow stability alongside rising debt, despite strong revenue growth. Technicals are mixed with the stock below longer-term moving averages, while a modest P/E and positive dividend yield provide partial support.
Positive Factors
Revenue Growth
Multi-year top-line growth to ¥6.7B in 2026 indicates sustained market demand and successful scale-up of operations. A larger revenue base supports investment in product/service offerings and distribution, increasing resilience and capacity to absorb short-term shocks over the next several months.
Negative Factors
Profitability Volatility
Large swings in net income and compressed margins indicate inconsistent earnings quality and weak operating leverage. This unpredictability complicates budgeting, reduces investor confidence, and means profitability may not be reliably sustained without structural cost or pricing improvements.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Multi-year top-line growth to ¥6.7B in 2026 indicates sustained market demand and successful scale-up of operations. A larger revenue base supports investment in product/service offerings and distribution, increasing resilience and capacity to absorb short-term shocks over the next several months.
Read all positive factors
Medical Net,Inc. (3645) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥2.14B
Dividend Yield1.24%
Average Volume (3M)13.39K
Price to Earnings (P/E)16.2
Beta (1Y)0.48
Revenue Growth10.84%
EPS GrowthN/A
CountryJP
Employees296
SectorCommunication Services
Sector Strength97
IndustryInternet Content & Information
Share Statistics
EPS (TTM)14.91
Shares Outstanding10,773,000
10 Day Avg. Volume10,010
30 Day Avg. Volume13,390
Financial Highlights & Ratios
PEG Ratio-0.06
Price to Book (P/B)1.24
Price to Sales (P/S)0.37
P/FCF Ratio27.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Medical Net,Inc. Business Overview & Revenue Model
Company Description
Medical Net, Inc. provides a comprehensive business platform for dental medicine. The company engages in the management and operation of portal websites, provides marketing and management support for dental clinics, and develops and installs POS s...
How the Company Makes Money
null...
Medical Net,Inc. Financial Statement Overview
Summary
Income Statement
66
Positive
Balance Sheet
64
Positive
Cash Flow
52
Neutral
| Breakdown | May 2025 | May 2024 | May 2023 | May 2022 | May 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 6.73B | 6.07B | 5.25B | 4.50B | 3.75B |
| Gross Profit | 1.99B | 1.96B | 1.84B | 1.78B | 1.46B |
| EBITDA | 264.15M | 170.87M | 351.75M | 442.45M | 479.57M |
| Net Income | 137.50M | -68.15M | 5.96M | 116.18M | 380.10M |
Balance Sheet | |||||
| Total Assets | 4.57B | 4.08B | 3.99B | 3.47B | 3.15B |
| Cash, Cash Equivalents and Short-Term Investments | 1.96B | 1.46B | 1.53B | 1.52B | 1.13B |
| Total Debt | 1.42B | 1.26B | 1.03B | 790.83M | 773.54M |
| Total Liabilities | 2.50B | 2.31B | 2.06B | 1.54B | 1.42B |
| Stockholders Equity | 1.99B | 1.72B | 1.91B | 1.92B | 1.70B |
Cash Flow | |||||
| Free Cash Flow | 89.54M | -212.40M | 86.79M | 408.50M | 340.39M |
| Operating Cash Flow | 98.84M | -80.86M | 119.59M | 429.13M | 342.55M |
| Investing Cash Flow | 87.46M | -259.73M | -285.40M | -62.37M | -355.05M |
| Financing Cash Flow | 290.62M | 219.18M | 144.11M | -17.90M | 282.17M |
Medical Net,Inc. Technical Analysis
Negative
298.00
Price Trends
241.20
Positive
264.89
Negative
281.43
Negative
Market Momentum
-0.67
Negative
46.60
Neutral
33.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3645, the sentiment is Negative. The current price of 298 is above the 20-day moving average (MA) of 243.30, above the 50-day MA of 241.20, and above the 200-day MA of 281.43, indicating a neutral trend. The MACD of -0.67 indicates Negative momentum. The RSI at 46.60 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3645.
Medical Net,Inc. Peers Comparison
UnderperformOutperform
Sector (60)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥377.46B | 21.12 | ― | ― | 24.19% | 20.37% | |
76 Outperform | ¥50.40B | 44.19 | ― | ― | 30.21% | 488.52% | |
73 Outperform | ¥20.33B | 19.92 | ― | ― | 31.11% | 0.55% | |
62 Neutral | ¥2.14B | 16.23 | ― | 1.01% | 10.84% | ― | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
58 Neutral | ¥6.81B | 22.47 | ― | ― | 6.06% | 1.12% | |
51 Neutral | ¥4.72B | -9.18 | ― | 0.29% | -8.10% | -833.44% |
* Communication Services Sector Average
JP:3645
Medical Net,Inc.
242.00
-74.61
-23.56%
JP:2454
All About, Inc.
345.00
-51.88
-13.07%
JP:4176
coconala Inc.
291.00
-176.00
-37.69%
JP:4194
Visional, Inc.
9,261.00
-2,754.00
-22.92%
JP:5139
OpenWork Inc.
957.00
-284.33
-22.91%
JP:5243
note inc.
2,550.00
1,163.00
83.85%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.